Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Ina Research Inc (2176)

Tokyo
Currency in JPY
Disclaimer
899.0
0.0(0.00%)
Closed
2176 Scorecard
Fair Value
Unlock Value
Day's Range
898.0899.0
52 wk Range
566.0900.0
Bid/Ask
898.00 / 900.00
Prev. Close
898
Open
898
Day's Range
898-899
52 wk Range
566-900
Volume
0
Average Vol. (3m)
27,348
1-Year Change
0%
Shares Outstanding
2,998,800
Fair Value
Unlock
Dividends Payment Streak
Unlock
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Daily
Weekly
Monthly
More
How do you feel today about 2176?
Vote to see community's results!
or

Ina Research Inc Company Profile

Ina Research Inc., a consulting company, provides non-clinical and clinical studies services primarily in Japan. It offers Toxicology, Safety Pharmacology, Drug Dependence, Drug Efficacy, and QT/QTc studies, as well as support services for a range of non-clinical toxicity studies for pharmaceutical development, from the screening stage to preparation for clinical trials. The company also provides safety assessment of chemicals and agrichemicals. In addition, it offers efficacy studies for central nervous system, circulatory system, osteology, ophthalmology, blood glucose, nephritis, renal failure, total parenteral nutrition, and others; and clinical trial services, including QT/QTc studies. Further, the company provides health food studies comprising non-clinical studies; analysis services, including clinical pathology, pathology, and metabolism and chemical analysis; translation services for various non-clinical studies ranging from Japanese to English and vice versa; and quality assurance services for various studies. Additionally, it offers environmental equipment, published papers, and seminars archives. The company was formerly known as Shinshu Non-Clinical Laboratory Center and changed its name to Ina Research Inc. in July 1989. Ina Research Inc. was founded in 1974 and is headquartered in Ina, Japan. As of July 13, 2022, Ina Research Inc. operates as a subsidiary of Shin Nippon Biomedical Laboratories, Ltd..

Employees
175
Market
Japan
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.